Concert Pharmaceuticals Inc

NASDAQ:CNCE   12:59:28 PM EDT
6.77
-0.26 (-3.70%)
Earnings Announcements

Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 11:32 GMT
Concert Pharmaceuticals Inc (CNCE) - Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results.
Concert Pharmaceuticals Inc - Expects Its Cash, Cash Equivalents and Investments to Fund Company Into Q2 of 2023.
Concert Pharmaceuticals Inc Qtrly Net Loss per Share Applicable to Common Stockholders - Basic and Diluted $0.59 .
Revenue is expected to be $0.17 Million
Adjusted EPS is expected to be -$0.59

Next Quarter Revenue Guidance is expected to be $0.17 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.